These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 890999)

  • 21. Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects.
    Millar JA; Fraser R; Mason P; Leckie B; Cumming AM; Robertson JI
    Br J Clin Pharmacol; 1984 Sep; 18(3):369-75. PubMed ID: 6386025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary hyperparathyroidism associated with primary hyperaldosteronism.
    Ferriss JB; Brown JJ; Cumming AM; Fraser R; Lever AF; Peacock M; Robertson JI
    Acta Endocrinol (Copenh); 1983 Jul; 103(3):365-70. PubMed ID: 6349207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
    Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET
    Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of moduretic and hydrochlorothiazide in the treatment of hypertension in African patients.
    Salako LA; Falase AO
    East Afr Med J; 1973 Jan; 50(1):38-47. PubMed ID: 4720446
    [No Abstract]   [Full Text] [Related]  

  • 25. Relation of blood pressure with body and plasma electrolytes in Conn's syndrome.
    Beretta-Piccoli C; Davies DL; Brown JJ; Ferriss B; Fraser R; Lasaridis A; Lever AF; Morton JJ; Robertson JI; Semple PF
    J Hypertens; 1983 Aug; 1(2):197-205. PubMed ID: 6681039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinico-functional evaluation of a new potassium-sparing diuretic: amiloride].
    Boschetti E; Dottorini M; Bentivoglio M; Losito A; Grassi V; Muiesan G
    Clin Ter; 1977 Mar; 80(6):530-6. PubMed ID: 862353
    [No Abstract]   [Full Text] [Related]  

  • 27. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
    Stockigt JR; Scoggins BA
    J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term effect of timolol and hydrochlorothiazide, or hydrochlorothiazide and amiloride, in essential hypertension.
    Castenfors H
    Eur J Clin Pharmacol; 1977 Oct; 12(2):97-103. PubMed ID: 336379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrochlorothiazide-amiloride versus hydrochlorothiazide alone for essential hypertension: effects on blood pressure and serum potassium level.
    Larochelle P; Logan AG
    Can Med Assoc J; 1985 Apr; 132(7):801-5. PubMed ID: 3884122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.
    Lasaridis A; Brown JJ; Davies DL; Fraser R; Robertson JI; Lever AF
    J Hypertens; 1984 Aug; 2(4):329-36. PubMed ID: 6530544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive and metabolic effects of a combination of hydrochlorothiazide and amiloride.
    Leary WP; Reyes AJ
    S Afr Med J; 1981 Sep; 60(10):381-4. PubMed ID: 7025258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of amiloride on arterial pressure and renal function.
    Chrysant SG; Luu TM
    J Clin Pharmacol; 1980; 20(5-6 Pt 1):332-7. PubMed ID: 7400369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similarity of idiopathic aldosteronism and essential hypertension. A statistical comparison.
    McAreavey D; Murray GD; Lever AF; Robertson JI
    Hypertension; 1983; 5(1):116-21. PubMed ID: 6336718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration.
    Ferriss JB; Brown JJ; Fraser R; Haywood E; Davies DL; Kay AW; Lever AF; Robertson JI; Owen K; Peart WS
    Br Med J; 1975 Jan; 1(5950):135-8. PubMed ID: 234268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition?
    Davies DL; Beevers DG; Brown JJ; Cumming AM; Fraser R; Lever AF; Mason PA; Morton JJ; Robertson JI; Titterington M; Tree M
    J Endocrinol; 1979 May; 81(2):79P-91P. PubMed ID: 458346
    [No Abstract]   [Full Text] [Related]  

  • 36. Body elemental composition, with particular reference to total and exchangeable sodium and potassium and total chlorine, in untreated and treated primary hyperaldosteronism.
    Williams ED; Boddy K; Brown JJ; Cumming AM; Davies DL; Harvey IR; Haywood JK; Lever AF; Robertson JI
    J Hypertens; 1984 Apr; 2(2):171-6. PubMed ID: 6533185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Primary hyperaldosteronism].
    Plouin PF; Massien-Simon C
    Rev Prat; 1998 Apr; 48(7):749-53. PubMed ID: 11767370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The renin-angiotensin-aldosterone system in hypertensive patients. II. Diagnosis of primary hyperaldosteronism].
    Corvol P; Houde M; Benguigui L; Tonnelier M; Menard J; Milliez P
    Nouv Presse Med; 1977 Sep; 6(29):2569-72. PubMed ID: 909737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic value of calcium antagonists in autonomous hyperaldosteronism.
    Stimpel M; Ivens K; Volkmann HP; Wambach G; Kaufmann W
    Klin Wochenschr; 1989 Feb; 67(4):248-52. PubMed ID: 2648061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral potassium chloride and amiloride in hydrochlorothiazide-induced potassium loss.
    Maronde RF; Barr J; Vlachakis ND; Spencer CA; Chan L
    Clin Pharmacol Ther; 1984 Oct; 36(4):431-5. PubMed ID: 6478730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.